Actively Recruiting
Phenotypic Exploration of Autism Spectrum Disorders Retrospective and Prospective Data
Led by Assistance Publique - Hôpitaux de Paris · Updated on 2022-04-18
1500
Participants Needed
1
Research Sites
313 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Autism Spectrum Disorders (ASD) are a heterogeneous group of severe developmental abnormalities of the nervous system characterized by deficits in social interaction and verbal and nonverbal communication affecting approximately 1% of the general population. In 5-40% of cases, genetic factors are identified as the cause of these disorders. Despite this unique definition and the advancement of techniques, ASD is still a clinically and genetically heterogeneous condition, as several hundred genes have been identified to date. Primary Objective and Endpoint Primary Objective: Exploration of phenotypic heterogeneity in patients with ASD. Primary endpoint: * Routine Care Clinical Investigation Criteria. * Scores on assessment scales,
CONDITIONS
Official Title
Phenotypic Exploration of Autism Spectrum Disorders Retrospective and Prospective Data
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Child under 18 years old diagnosed with Autism Spectrum Disorder
You will not qualify if you...
- None specified
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hôpital Robert Debré
Paris, France, 75019
Actively Recruiting
Research Team
A
Anna MARUANI, MD
CONTACT
R
Richard DELORME, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here